Learn more

FUNDACAO OSWALDO CRUZ

Overview
  • Total Patents
    324
  • GoodIP Patent Rank
    17,003
  • Filing trend
    ⇧ 17.0%
About

FUNDACAO OSWALDO CRUZ has a total of 324 patent applications. It increased the IP activity by 17.0%. Its first patent ever was published in 1988. It filed its patents most often in Brazil, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are FUNDAÇÃO OSWALDO CRUZ, UNIV YALE and INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE.

Patent filings per year

Chart showing FUNDACAO OSWALDO CRUZs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tendler Miriam 31
#2 Boechat Nubia 20
#3 Galler Ricardo 20
#4 Katz Naftale 18
#5 Simpson Andrew J G 15
#6 Ramos Celso Raul Romero 11
#7 Krieger Marco Aurelio 10
#8 Foti Leonardo 9
#9 Simpson Andrew John 8
#10 Bonaldo Myrna Cristina 8

Latest patents

Publication Filing date Title
WO2021035325A1 Protein receptacle, polynucleotide, vector, expression cassette, cell, method for producing the receptacle, method of identifying pathogens or diagnosing diseases, use of the receptacle and diagnostic kit
WO2020168402A1 Chimeric protein, method of production and use thereof, and also a nucleic acid molecule, expression cassette, expression vector, host cell, composition for the diagnosis of leishmaniasis, kit for the diagnosis of leishmaniasis and method of diagnosis of leishmaniasis in vitro
WO2020124188A1 Polypeptide with asparaginase activity, polynucleotide, expression cassette, expression vector, host cell, pharmaceutical composition, methods for producing a polypeptide with asparaginase activity and for preventing or treating neoplasms, and use of a polypeptide
WO2020113303A1 Recombinant protein, synthetic dna sequence, expression vector, host cell, composition, kit for diagnosing rubella, use of at least one recombinant protein and methods for producing a recombinant protein and for diagnosing rubella
WO2020082145A1 Polypeptide, expression cassette, expression vector, host cell, kit for immunological screening for hcv and/or for diagnosing hepatitis c, composition, use of at least one polypeptide and methods for producing a polypeptide, for immunological screening for hcv and for diagnosing hepatitis c
BR102019018557A2 QUINOLINE DERIVED COMPOUND, USE OF A COMPOUND, COMPOSITION, AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A CONDITION CAUSED BY A BLOOD PARASITE
EP3812768A1 Method for detecting antibodies against leishmania in a canine biological sample, kit for detection of leishmania infection in a biological sample, and use of leishmania lipophosphoglucan
CN111902212A LAMP detection device
BR102018073888A2 RECOMBINANT PROTEIN, SYNTHETIC DNA SEQUENCE, EXPRESSION CASSETTE, EXPRESSION VECTOR, HOSTING CELL, METHOD TO PRODUCE A RECOMBINANT PROTEIN, METHOD AND DETECTION OF CHEESE CHEESE, AN AGEOXYGENIC CHEESE, ETHICAL USE, EYEOLOGICAL COLLECTION
BR102018016140A2 RECOMBINANT OR SYNTHETIC PROTEIN, SYNTHETIC DNA SEQUENCE, EXPRESSION CASSETTE, EXPRESSION VECTOR, HOSTING CELL, METHOD OF PRODUCTION OF THE RECOMBINANT OR SYNTHETIC PROTEIN, COMPOSITION, USE OF THE RECOMBINANT, SYNTHETIC, SYNTHETIC OR SYNTHETIC PROTEIN FOR DIAGNOSIS OF CHAGAS DISEASE
WO2019028537A1 Multifunctional device for containing, transporting, storing and collecting biological samples from animals
WO2018184086A1 Oligonucleotides, set of oligonucleotides, and method for simultaneously detecting mayv, orov and orov-like, kit for diagnosing and discriminating mayv, orov and orov-like infections
WO2018170571A1 Immunodiagnostic method for acute and chronic toxoplasmosis
WO2018170572A1 Lateral flow diagnostic device with radial symmetry, and system for reading a lateral flow diagnostic device with radial symmetry
WO2018161141A1 Cryptococcus target genes
BR102018003245A2 oligonucleotide, oligonucleotide pool, method for simultaneous detection of neisseria meningitidis, streptococcus pneumoniae and haemophilus influenzae, and, kit.
US2020010515A1 Recombinant vaccine against helminths in pichia pastoris and methods for producing and purifying proteins for use as vaccines against helminths
BR102018001033A2 ASPARAGINASE ACTIVITY POLYPEPTIDE, EXPRESSION CASSETTE, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCING AN ASPARAGINASE ACTIVITY AND FOR PREVENTING OR TREATING, AND CANCERING, CANCER.
EP3533822A1 Method for activating the surface of polymer materials
US2019276500A1 Heterologous expression cassette, dna construct and vaccine composition to immunize against flavivirus and/or other pathogens